Our data highlight the difficulty of the study of sepsis-induced AKI due to a failure of traditional (BUN, serum creatinine) and emerging biomarkers (urine IL-6, urine NGAL), to accurately reflect the severity of kidney function decline. The gene discussed is LCN2; the disease is Sepsis.